Macquarie Group’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Macquarie Group’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-609	Closed	-$7K	–	1813
2022 Q4	$7K	Hold	609	–	–	﹤0.01%	1730
2022 Q3	$20K	Buy	+609	New	+$17.2K	﹤0.01%	2209

Macquarie Group's CINC Position: Q1 2023 in Review

Macquarie Group sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 609 shares — an estimated $7K sold.

Macquarie Group first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $20K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Macquarie Group reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Macquarie Group sold 609 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $7K.
Macquarie Group first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Macquarie Group's CinCor Pharma, Inc. Common Stock position peaked at $20K in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Macquarie Group's 13F filing for Q1 2023, filed 15 May 2023.